Eli Lilly Seeks To Expand Into Cancer Radiopharma And Fatty Liver, With Two Global Deals
Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for ...
forbesmiddleeast.com9d
100 Most Powerful Businesswomen 2025
Zaporozhets assumed her current role in January 2024, having joined Eli Lilly and Company in 2002. She oversaw the approval and launch of Kisluna, a drug for treating Alzheimer’s disease, in the U.A.E ...